Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul S Aisen

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
Journal of Pain and Symptom Management|May 7, 2002
Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's diseasePaul S Aisen
Neurology|May 29, 2008
Treatment for MCI: is the evidence sufficient?Paul S Aisen
Alzheimer Disease and Associated Disorders|March 5, 2008
The inflammatory hypothesis of Alzheimer disease: dead or alive?Paul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2008
Leon Thal and the therapeutic age of Alzheimer's diseasePaul S Aisen
CNS Spectrums|November 5, 2008
Amyloid-based therapeutics: findings translated into novel treatmentsPaul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United StatesPaul S Aisen
Nature Clinical Practice. Neurology|August 26, 2006
Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?Paul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2011
Commentary on "Biomarkers in Alzheimer's disease drug development." Can't live without 'emPaul S Aisen
JAMA|April 24, 2014
Serum brain-derived neurotrophic factor and the risk for dementiaPaul S Aisen
Neurobiology of Aging|October 11, 2011
Clinical trial methodologies for disease-modifying therapeutic approachesPaul S Aisen
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Journal of Pain and Symptom Management|May 7, 2002
Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's diseasePaul S Aisen
Neurology|May 29, 2008
Treatment for MCI: is the evidence sufficient?Paul S Aisen
Alzheimer Disease and Associated Disorders|March 5, 2008
The inflammatory hypothesis of Alzheimer disease: dead or alive?Paul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2008
Leon Thal and the therapeutic age of Alzheimer's diseasePaul S Aisen
CNS Spectrums|November 5, 2008
Amyloid-based therapeutics: findings translated into novel treatmentsPaul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United StatesPaul S Aisen
Nature Clinical Practice. Neurology|August 26, 2006
Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?Paul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2011
Commentary on "Biomarkers in Alzheimer's disease drug development." Can't live without 'emPaul S Aisen
JAMA|April 24, 2014
Serum brain-derived neurotrophic factor and the risk for dementiaPaul S Aisen
Neurobiology of Aging|October 11, 2011
Clinical trial methodologies for disease-modifying therapeutic approachesPaul S Aisen
Pageof 28